Covishield in open market after March-April: Serum Institute of India

The Pune-based #SerumInstituteofIndia (SII) could make the #Covid19 vaccine by AstraZeneca-Oxford University available in India’s market after March-April next year, the company has told this newspaper. SII is the manufacturing partner for #Covishield and is also sponsoring phase 2, 3 trial of the vaccine on 1,600 volunteers.